PROMIS NEUROSCIENCES INC. - Common Shares (PMN)

CUSIP: 74346M406

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Shares
Shares outstanding
8,977,479
Total 13F shares
3,347,909
Share change
+543,290
Total reported value
$3,849,710
Price per share
$1.15
Number of holders
13
Value change
+$624,784
Number of buys
3
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 74346M406?
CUSIP 74346M406 identifies PMN - PROMIS NEUROSCIENCES INC. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PMN - PROMIS NEUROSCIENCES INC. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
20%
1,834,042
$3,686,424 30 Sep 2023
13F
Ally Bridge Group (NY) LLC
13F
Company
5.9%
531,915
$1,053,351 30 Sep 2023
13F
Affinity Asset Advisors, LLC
13F
Company
3%
265,958
$526,677 30 Sep 2023
13F
Gail M. Farfel
3/4/5
Chief Executive Officer, Director
mixed-class rows
108,384
mixed-class rows
$256,091 23 Aug 2023
Northeast Financial Consultants Inc
13F
Company
1.1%
100,000
$198,030 30 Sep 2023
13F
IEQ CAPITAL, LLC
13F
Company
0.44%
39,191
$77,610 30 Sep 2023
13F
FIDUCIARY TRUST CO
13F
Company
0.22%
20,008
$39,622 30 Sep 2023
13F
Claret Asset Management Corp
13F
Company
0.12%
10,830
$22,000 30 Sep 2023
13F
Gavin T. Malenfant
3/4/5
Chief Operating Officer, Director
mixed-class rows
17,820
mixed-class rows
$12,342 26 Oct 2023
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
1,666
$3,299 30 Sep 2023
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
713
$1,000 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
0%
388
$780 30 Sep 2023
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
333
$633 30 Sep 2023
13F
TD Waterhouse Canada Inc.
13F
Company
0%
149
$391 30 Sep 2023
13F
AllSquare Wealth Management LLC
13F
Company
0%
185
$366 30 Sep 2023
13F
UBS Group AG
13F
Company
0%
103
$204 30 Sep 2023
13F
Daniel E. Geffken
3/4/5
Chief Financial Officer
class O/S missing
2,500
26 Oct 2023

Institutional Holders of PROMIS NEUROSCIENCES INC. - Common Shares (PMN) as of Q4 2023

As of 31 Dec 2023, PROMIS NEUROSCIENCES INC. - Common Shares (PMN) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,347,909 shares. The largest 10 holders included SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Affinity Asset Advisors, LLC, Northeast Financial Consultants Inc, IEQ CAPITAL, LLC, FIDUCIARY TRUST CO, Kingsview Wealth Management, LLC, Claret Asset Management Corp, UBS Group AG, and BANK OF AMERICA CORP /DE/. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
13
Q4 2023 holders
13
Holder diff
0
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .